Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
BBB
BBB Overview
Year Founded
2014
Status
Private
Employees
2
Latest Deal Type
Series B
Latest Deal Amount
$16.5M
Investors
8
BBB General Information
Description
Developer of an integrated mobile healthcare platform designed to detect early-stage cancer and severe disorders in a speedy and accurate manner. The company's platform develops a product that uses artificial intelligence to gather and analyze blood biomarkers for cancer diagnosis through a single drop of blood, enabling patients to regularly test their blood for cancer markers in the comforts of their homes and physicians to easily monitor health markers remotely.